期刊
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
卷 15, 期 5, 页码 478-485出版社
WILEY
DOI: 10.1111/j.1756-185X.2012.01814.x
关键词
B lymphocyte stimulator (BlyS); rheumatoid arthritis; sero-negative; sero-positive
类别
Aim To investigate the differences of B lymphocyte stimulator (BlyS) level and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis (RA) patients. Methods Sixty-nine RA patients were enrolled into this study and their clinical data were recorded. The BlyS levels in plasma, frequency of T and B lymphocytes, as well as T-helper (Th) subgroups were compared between sero-negative and sero-positive RA patients. Furthermore, the correlations between clinical features and immunological features were analyzed. Results The plasma BlyS level in sero-negative RA was higher compared to the sero-positive RA patients (1.73 +/- 1.71 vs. 0.99 +/- 0.59 ng/mL, P < 0.05) and osteoarthritis (OA) patients (1.73 +/- 1.71 vs. 0.59 +/- 0.12 ng/mL, P < 0.05). Plasma BlyS level was correlated with disease activity score (DAS-28, erythrocyte sedimentation rate and C-reactive protein), but had no correlation with the titers of rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies. The patients with more advanced changes in X-rays had high plasma BlyS levels. No significant differences in the frequency of T lymphocytes, Th subpopulations and B lymphocytes in peripheral blood were observed between sero-negative and sero-positive RA patients. Conclusions Plasma BlyS level was correlated with disease activity and radiological progress, which indicates that plasma BlyS level may become a useful biological marker to reflect DAS and to predict RA prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据